Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
54
54 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- U16Phase 21 trial
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd · Relapsed or Refractory Non-Hodgkin's Lymphoma
- UCART20x22Phase 21 trial
Cellectis S.A. · B-cell Non-Hodgkin Lymphoma (B-NHL)
- VI-0609Phase 21 trial
VIVUS LLC · Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma
- WTX-330Phase 21 trial
Werewolf Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.